In this preliminary, short-term study of patients with previous coronary restenosis, coronary stenting followed by catheter-based intracoronary radiotherapy substantially reduced the rate of subsequent restenosis.
Background
—Although several early trials indicate treatment of restenosis with radiation therapy is safe and effective, the long-term impact of this new technology has been questioned. The objective of this report is to document angiographic and clinical outcome 3 years after treatment of restenotic stented coronary arteries with catheter-based
192
Ir.
Methods and Results
—A double-blind, randomized trial compared
192
Ir with placebo sources in patients with previous restenosis after coronary angioplasty. Over a 9-month period, 55 patients were enrolled; 26 were randomized to
192
Ir and 29 to placebo. At 3-year follow-up, target-lesion revascularization was significantly lower in the
192
Ir group (15.4% versus 48.3%;
P
<0.01). The dichotomous restenosis rate at 3-year follow-up was also significantly lower in
192
Ir patients (33% versus 64%;
P
<0.05). In a subgroup of patients with 3-year angiographic follow-up not subjected to target-lesion revascularization by the 6-month angiogram, the mean minimal luminal diameter between 6 months and 3 years decreased from 2.49±0.81 to 2.12±0.73 mm in
192
Ir patients but was unchanged in placebo patients.
Conclusions
—The early clinical benefits observed after treatment of coronary restenosis with
192
Ir appear durable at late follow-up. Angiographic restenosis continues to be significantly reduced in
192
Ir-treated patients, but a small amount of late loss was observed between the 6-month and 3-year follow-up time points. No events occurred in the
192
Ir group to suggest major untoward effects of vascular radiotherapy. At 3-year follow-up, vascular radiotherapy continues to be a promising new treatment for restenosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.